Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). (Q36318487)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). |
scientific article |
Statements
1 reference
Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A). (English)
1 reference
Schapira AH
1 reference
Hanna MG
1 reference
Morgan-Hughes JA
1 reference
Stewart J
1 reference
Wood NW
1 reference
Murray NM
1 reference
1 reference
Identifiers
1 reference